Recombinant Pseudomonas putida Flavohemoprotein (hmp)

Shipped with Ice Packs
In Stock

Description

Genetic Regulation and Expression

The hmp gene in P. putida is regulated by the σ54-dependent transcriptional activator FhpR, which responds to NO . Recombinant expression systems leverage:

  • Promoter Systems: Synthetic or inducible promoters (e.g., Ptac, Plac) to drive hmp expression .

  • Host Strains: Engineered P. putida KT2440 variants with enhanced metabolic vigor and reduced protease activity for high-yield production .

Table 1: Key Genetic Modifications for Recombinant Hmp Production

ModificationPurposeOutcome
Deletion of mscLReduces cell lysis during fermentationImproved protein stability
oprFE overexpressionEnhances membrane permeabilityIncreased export efficiency
hsdRMS operon deletionEliminates restriction-modificationFacilitates plasmid retention

Biotechnological Applications

Recombinant Hmp has potential in:

  • Bioremediation: Degradation of nitrogen oxides in contaminated environments.

  • Industrial Biocatalysis: Protecting enzymes in aerobic bioprocesses from NO inhibition .

  • Synthetic Biology: Integration into microbial chassis for stress-resistant metabolic pathways .

Research Findings

  • NO Detoxification Efficiency: Recombinant P. putida expressing Hmp shows a 50% reduction in intracellular NO levels under microaerobic conditions .

  • Cross-Species Functionality: P. putida Hmp complements NO sensitivity in E. coli hmp mutants, confirming functional conservation .

  • Structural Insights: Crystal structures of homologous flavohemoglobins (e.g., PDB 1LVL) reveal conserved active-site residues critical for NO oxidation .

Challenges and Future Directions

  • Expression Optimization: Balancing Hmp production with host fitness remains challenging due to metabolic burden .

  • In Vivo Dynamics: Real-time monitoring of Hmp activity in bioreactors requires advanced biosensors .

Product Specs

Form
Lyophilized powder

Note: We will prioritize shipping the format currently in stock. However, please specify any format requirements in your order notes, and we will accommodate your request to the best of our ability.

Lead Time
Delivery times vary depending on the purchasing method and location. Please contact your local distributor for precise delivery estimates.

Note: All proteins are shipped with standard blue ice packs. Dry ice shipping is available upon request and incurs an additional charge. Please contact us in advance to arrange this.

Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Before opening, briefly centrifuge the vial to collect the contents. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50% and may serve as a guideline.
Shelf Life
Shelf life depends on various factors including storage conditions, buffer composition, temperature, and the protein's inherent stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is recommended for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.

The tag type is determined during the production process. If you require a specific tag, please inform us, and we will prioritize its development.

Synonyms
hmp; hmpA; PP_0808; Flavohemoprotein; Flavohemoglobin; Hemoglobin-like protein; Nitric oxide dioxygenase; NO oxygenase; NOD; EC 1.14.12.17
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-392
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Pseudomonas putida (strain ATCC 47054 / DSM 6125 / NCIMB 11950 / KT2440)
Target Names
hmp
Target Protein Sequence
MLNAEQRAII KATVPLLESG GEALTTHFYK MMLSEYPEVR PLFNQAHQAS GDQPRALANG VLMYARHIDQ LEQLGGLVGQ IINKHVALQI LPEHYPIVGS CLLRAIEEVL GKDIATPAVI DAWGAAYGQL ADILIGAEEN LYKEKEEAEG GWRGTREFRL VRREQESSEI VSFYFAPVDG MPVLKAEPGQ YIGLKLDIDG AEQRRNYSLS ALCDGKEYRI SVKREAGGKV SNYLHDELKV GDTLQLFPPA GDFTLAASDK PLVLISGGVG ITPTLAMLQA ALQTRREVHF IHCARNGAVH AFRDWIDGLA ARHPQLKRFY CYAEPEGGAA ADAVGLLSED LLAEWLPQER DVDAYFLGPK GFMAAVKRQL KGLGVPEQQS RYEFFGPAAA LE
Uniprot No.

Target Background

Function

This flavohemoprotein participates in aerobic nitric oxide detoxification, specifically the nitric oxide dioxygenase (NOD) reaction. This reaction utilizes O2 and NAD(P)H to convert NO to nitrate, thus protecting the bacterium from harmful nitrogenous compounds. Consequently, this protein plays a crucial role in the inducible response to nitrosative stress.

Database Links

KEGG: ppu:PP_0808

STRING: 160488.PP_0808

Protein Families
Globin family, Two-domain flavohemoproteins subfamily; Flavoprotein pyridine nucleotide cytochrome reductase family

Q&A

What is recombinant Pseudomonas putida flavohemoprotein (hmp), and why is it significant in research?

Recombinant Pseudomonas putida flavohemoprotein (hmp) is a genetically engineered variant of the flavohemoprotein enzyme expressed in the bacterium Pseudomonas putida. Flavohemoproteins are dual-function enzymes that contain both a flavin adenine dinucleotide (FAD)-binding domain and a heme-binding domain, enabling them to participate in redox reactions and nitric oxide detoxification. The significance of recombinant hmp lies in its applications in studying oxidative stress responses, bioremediation, and synthetic biology.

The use of Pseudomonas putida as a host organism for recombinant expression offers several advantages. This bacterium is highly adaptable, with a robust metabolism capable of tolerating xenobiotics and high oxidative stress. These properties make it an ideal chassis for producing recombinant proteins like hmp. Furthermore, hmp's ability to neutralize reactive nitrogen species (RNS) has implications for understanding microbial resistance mechanisms and developing biotechnological solutions for environmental challenges .

How can one design experiments to optimize the expression of recombinant hmp in Pseudomonas putida?

Experimental design for optimizing hmp expression involves several critical steps:

  • Selection of Promoters: The choice of promoter significantly influences the expression level of recombinant hmp. Inducible promoters such as the XylS/Pm system, which is activated by 3-methylbenzoate, allow controlled expression levels. Researchers must evaluate promoter strength using reporter assays like GFP fluorescence or enzymatic activity measurements .

  • Codon Optimization: Since codon usage varies among organisms, optimizing the hmp gene sequence to match the codon preferences of Pseudomonas putida can enhance translation efficiency.

  • Plasmid Vector Selection: Broad-host-range plasmids like pSEVA238 are commonly used for expressing recombinant proteins in Pseudomonas putida. These vectors should include features such as antibiotic resistance markers and multiple cloning sites .

  • Culture Conditions: Factors such as temperature, pH, and nutrient composition impact protein expression. For example, lower temperatures may reduce protein aggregation and improve solubility.

  • Induction Strategies: The timing and concentration of inducers like 3-methylbenzoate must be optimized to balance growth and protein production.

  • Analytical Techniques: Methods such as SDS-PAGE, Western blotting, and mass spectrometry are used to confirm protein expression and purity.

Table 1 summarizes key experimental parameters for optimizing hmp expression:

ParameterRecommended Approach
PromoterXylS/Pm inducible system
Codon OptimizationMatch codon usage to Pseudomonas putida
VectorBroad-host-range plasmids (e.g., pSEVA238)
Temperature20-30°C
Inducer3-methylbenzoate (concentration-dependent)

What are the challenges associated with purifying recombinant hmp from Pseudomonas putida?

Purifying recombinant hmp involves overcoming several challenges:

  • Protein Solubility: Recombinant proteins often form inclusion bodies due to improper folding. This can be mitigated by co-expressing chaperones or lowering the culture temperature during expression .

  • Contaminants: The host's native proteins can co-purify with recombinant hmp, complicating downstream processes. Affinity chromatography using tags like His-tag or Strep-tag facilitates selective purification.

  • Stability: Flavohemoproteins are prone to oxidative damage due to their role in redox reactions. Adding reducing agents like dithiothreitol (DTT) during purification can preserve enzyme activity.

  • Yield Optimization: Achieving high yields requires balancing expression levels with cell viability. Overexpression can lead to metabolic burden and reduced growth rates.

  • Post-Translational Modifications: While rare in bacterial systems, post-translational modifications may affect protein function and require additional verification steps.

Researchers typically use a combination of chromatographic techniques—such as ion exchange, size exclusion, and affinity chromatography—to achieve high purity levels.

How does nitric oxide (NO) influence the regulation of flavohemoprotein genes in Pseudomonas species?

Nitric oxide (NO) plays a crucial role in regulating flavohemoprotein genes through NO-responsive transcriptional regulators such as FhpR in Pseudomonas aeruginosa. In Pseudomonas putida, similar regulatory mechanisms are hypothesized but not fully characterized .

The regulatory cascade involves the activation of σ54-dependent promoters by FhpR in response to NO or related reactive nitrogen species (RNS). This activation ensures that flavohemoproteins are expressed when cells encounter nitrosative stress conditions.

Experimental approaches to study NO regulation include:

  • Promoter Activity Assays: Reporter constructs with luciferase or GFP under the control of the fhp promoter can quantify NO-induced transcriptional activity.

  • Mutant Strains: Creating knockout strains deficient in key regulators like FhpR allows researchers to dissect their roles in gene regulation.

  • Electrophoretic Mobility Shift Assays (EMSAs): These assays confirm direct binding of regulatory proteins to fhp promoter sequences.

  • Quantitative PCR (qPCR): Measuring fhp mRNA levels under varying NO concentrations provides insights into transcriptional dynamics.

Understanding NO regulation has implications for microbial physiology and biotechnology applications, such as engineering bacteria for enhanced RNS detoxification .

What experimental strategies can be employed to study the enzymatic activity of recombinant hmp?

To study the enzymatic activity of recombinant hmp, researchers employ various biochemical and biophysical techniques:

  • Spectrophotometric Assays: Flavohemoproteins exhibit characteristic absorbance spectra due to their heme groups. Monitoring changes in absorbance at specific wavelengths (e.g., 415 nm for Soret band) provides information about enzyme activity.

  • Nitric Oxide Scavenging Assays: These assays measure the ability of hmp to detoxify NO using NO-sensitive dyes or electrodes.

  • Oxygen Consumption Measurements: Flavohemoproteins catalyze oxygen-dependent reactions that can be monitored using oxygen-sensitive probes.

  • Kinetic Analysis: Determining parameters such as KmK_m and VmaxV_{max} using Michaelis-Menten kinetics helps characterize enzyme efficiency under different conditions.

  • Site-Directed Mutagenesis: Altering specific amino acids within the active site allows researchers to identify residues critical for catalysis.

  • Structural Studies: Techniques like X-ray crystallography or NMR spectroscopy reveal structural details that correlate with function.

These strategies provide comprehensive insights into hmp's catalytic mechanisms and potential applications .

How can data contradictions regarding hmp functionality be resolved?

Data contradictions often arise due to differences in experimental conditions or methodologies across studies. Resolving these discrepancies requires:

  • Standardization of Protocols: Ensuring consistent experimental conditions—such as pH, temperature, and substrate concentrations—reduces variability.

  • Replication Studies: Independent replication of experiments by different research groups validates findings.

  • Meta-Analysis: Combining data from multiple studies using statistical methods identifies overarching trends despite individual inconsistencies.

  • Advanced Analytical Tools: Techniques like mass spectrometry or high-throughput sequencing provide more precise measurements that clarify ambiguous results.

  • Hypothesis Testing: Designing experiments specifically aimed at testing conflicting hypotheses helps resolve uncertainties.

For example, discrepancies regarding NO detoxification efficiency may stem from variations in NO delivery methods or detection systems used across studies .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.